(November 29, 2018)
Sponsored by
Webinar Description:
One of the main objectives of informatics in healthcare is to improve the quality of life and drive improvements across the care continuum. The tremendous growth in the health informatics field was spurred
in large part by the acceleration of electronic health records (EHR), allowing Physicians to capture a better view of their patients’ overall health and enabling faster and accurate diagnoses and appropriate personalized treatments. The
automation of previously manual tasks saves time and money for physicians, insurers, and patients alike.
With the continued accumulation of data, Providers will have the opportunity to utilize ‘real-world’ outcome data to reveal trajectories of disease progression, inform shared decision making for episodic care, and act as a trigger for
clinical decisions.
However, much of the success of health informatics relies on the early and intensive consideration of the needs of the users of the technology. The application of health informatics across a range of modalities, including medical imaging and diagnostics,
drug discovery, and hospital workflow means that value creation is likely to be complex.
This webinar will provide an overview of the health informatics field and its effect on the continued expansion of Value-Based Healthcare and the future of personalized medicine. Evidence generation for health informatics to communicate value to support
future developments will also be discussed.
Speakers:
Joseph V. Ferrara
President and CEO
Boston Healthcare Associates, Inc.
Joe Ferrara has over 20 years of experience in life sciences consulting, working with biopharmaceutical, medical device, diagnostics, and informatics clients in market and business development strategy. He leads the global consulting team with practice
areas in reimbursement and pricing, health economics, market analysis, and business development strategy. Mr. Ferrara has extensive experience in the development of novel business approaches designed to capture evidence-based value for innovative
healthcare technologies. Mr. Ferrara writes and speaks extensively on the subject of the value of medical technology innovation, with a particular focus on pharmacogenomics, specialty pharmaceuticals, and novel therapeutic devices.
Prior to his consulting role, Mr. Ferrara led a joint venture between Boston Healthcare and a non-profit research organization focused on a global electronic medical record network for the purposes of clinical trials and health outcomes research.
Mr. Ferrara completed undergraduate studies at the University of Cincinnati and received a master’s degree from Harvard University.
Mark Girardi
Vice President
Boston Healthcare Associates, Inc.
Mark Girardi has over 30 years of experience in life sciences, in vitro diagnostics, and medical devices commercialization and reimbursement. He has had roles in product management, sales and marketing, and most recently in strategy consulting.
Mr. Girardi joins Boston Healthcare from GfK Health, a global consultancy and market research firm, where he was Senior Vice President responsible for the MedTech consulting practice. Prior to joining GfK, Mr. Girardi spent five years at Predictive
Biosciences as VP of Sales and Marketing. He also served as Senior Director of Marketing at Z-Tech Medical where he was responsible for commercialization of the company’s breast cancer screening devices. As a Director of Marketing at Cytyc
Corporation (now Hologic), he managed the worldwide launch of the Thin Prep Imaging System. Mark has also held senior marketing positions at Genzyme Genetics and Millipore.
Mr. Girardi received his BS in Chemistry from Merrimack College and an MS in Analytical Chemistry from the University of New Hampshire.
(November 29, 2018)